Trials / No Longer Available
No Longer AvailableNCT01374282
Post Marketing Surveillance Study of Cuprimine
Post Marketing Surveillance Study of Cuprimine (MK-0172-001)
- Status
- No Longer Available
- Phase
- —
- Study type
- Expanded Access
- Enrollment
- —
- Sponsor
- Merck Sharp & Dohme LLC · Industry
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
Cuprimine (penicillamine) was made available in the Philippines by the Sponsor under a Compassionate Special Permit issued by the Bureau of Food and Drugs. Physicians were able to request the drug for their patients from the Sponsor. A Clinical Study Report form was completed for each purchase of Cuprimine.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Cuprimine (penicillamine) | Dosage determined by the physician based on indication for treatment |
Timeline
- First posted
- 2011-06-15
- Last updated
- 2015-10-22
Source: ClinicalTrials.gov record NCT01374282. Inclusion in this directory is not an endorsement.